The Fresenius Sustainability Framework
We continuously advance our sustainability efforts and align with market expectations.
Sustainability
We act today for a better tomorrow - a Fresenius Principle reflected in our sustainability strategy
Learn how we address sustainability across patient care, access and affordability, employee engagement, climate and energy, water stewardship, circularity, quality, human rights, and business ethics. This section provides information on our sustainability targets, initiatives, and reported performance in these areas.
Why sustainability matters
Our goal is to create value for patients and employees. we consider sustainability-related topics as part of our business activities and decision-making processes. Our approach is reflected in the objectives, targets, and performance indicators presented in this section of our website.
This includes, for example:
- Tracking our portfolio's alignment with essential medicine lists in major markets to show our impact on patient care and healthcare systems.
- Monitoring greenhouse gas emissions in our operations and along the value chain and reporting progress against our published targets.*
- Providing our employees with a safe and supporting working environment and maintaining strong governance, compliance, and human rights standards.
To enhance transparency and accountability, we have set measurable sustainability targets and continuously monitor our performance.*
Explore our sustainability-related objectives, activities, and reported performance.
If you have questions about our sustainability initiatives, please contact us directly at sustainability@fresenius-kabi.com.
*For details on targets, methodologies, and progress, please refer to our Sustainability Statement.
The Sustainability Framework serves as the group-wide strategic framework for integrating environmental, social, and governance (ESG) considerations into our operations. It guides our daily actions and demonstrates how we embed sustainability into our business.
Human Dimension
Patient Centricity: Patient centricity at Fresenius means prioritizing patient needs, experiences, and outcomes when designing and delivering care through medical products and services in inpatient and outpatient settings.
Access & Affordability: We strive to provide affordable, high-quality products and services that are accessible to more patients, supporting healthcare system efficiency and its long-term stability.
Employee Engagement & Development: We strive to provide affordable, high-quality products and services that are accessible to more patients, supporting healthcare system efficiency and its long-term stability.
Find out more about Employee Development & Well-being at Fresenius Kabi
Planet Dimension
Decarbonization: Decarbonization at Fresenius means reducing greenhouse gas emissions across our operations and value chain.
Water: Water at Fresenius means using water responsibly and preserving water quality, with a particular focus on reducing water withdrawal in water-stressed areas.
Circularity & Waste: Circularity & Waste at Fresenius means using resources more efficiently by embedding circular principles into our products, processes, waste management and value chains.
Find out more about Decarbonization, Water, and Circularity & Waste at Fresenius Kabi
Our Ethical Foundation
Quality Excellence: Quality excellence means a strong commitment to delivering leading product and service quality and safety, enabled by continuous improvement and operational effectiveness. We strive for excellence - without compromise on quality.
Human Rights: Human rights at Fresenius means a commitment to respecting internationally recognized human rights, embedded in our business practices and across our value chains.
Business Ethics: Business Ethics at Fresenius means a commitment to ethical and responsible business conduct, embedded in our values, standards, and governance structures.
Find out more about Business Ethics at Fresenius Kabi
Find out more about Quality at Fresenius Kabi
We measure what we care for
50%
Scope 1 and 2 emission reduction by 2030*
More about our decarbonization pathway
20%
process water reduction in water stress areas by 2030*
More about our water management
20%
increase in annual training hours per employee by 2030*
More about our workforce development
*For details on targets, methodologies, and progress, please refer to our Sustainability Statement.
Shaping sustainability in the future
Although we have made progress toward more sustainable operations, there is still work to be done. We will continue to pursue ambitious goals that strengthen patient care and broaden access to healthcare.
Our targets, actions, and progress are outlined on the following pages.
Human Dimension
Planet Dimension
Ethical Foundation
Improving lives through access, education, and support
At Fresenius Kabi, our promise Committed to Life drives everything we do. We are dedicated to advancing global health by prioritizing patient well-being and empowering our employees.
Providing access to affordable, high-quality healthcare
We strive to improve patients’ quality of life worldwide by providing access to high-quality, affordable medicines and innovative healthcare solutions. Our portfolio includes pharmaceuticals – generics and biosimilars – that offer cost-effective alternatives to originator drugs, as well as MedTech and Nutrition products that establish a solid foundation for patient care and recovery.
Impact at a glance
- Patients reached: In 2025, we reached 450 million patients by providing essential medicines, medical devices, and nutritional therapies.
- Essential medicines: In the United States, 67% of Fresenius Kabi IV drug units shipped in 2025 appear on the Food and Drug Administration (FDA) Essential Medicines List. In Europe, 69% of the total units of Fresenius Kabi generics product range sold in 2025 are part of the Union list of critical medicines by the European Medicines Agency.
- Affordability and system value: Access to high‑quality generics and biopharmaceuticals can support cost‑conscious care and help healthcare systems manage treatment needs.*
*Source: Medicines for Europe; IQVIA, “Beneath the Surface: Unravelling the True Value of Generic Medicines”, 2024
In 2025, we reached 450 million patients by providing essential medicines, medical devices, and nutritional therapies.
Strengthening supply chains to enhance patient care
Ensuring the availability of our products is vital to patient care. We continually invest in our global manufacturing network to maintain a reliable and resilient supply of life-saving therapies. By strengthening our supply infrastructure, we help prevent disruptions and enhance healthcare delivery worldwide.
Combating disease-related malnutrition with clinical nutrition
Fresenius Kabi provides a comprehensive range of clinical nutrition products designed to address malnutrition and meet the specific needs of vulnerable patients, including those with cancer or critical illnesses. The company actively engages in research, participating in approximately 30 studies and supporting scientific progress through initiatives such as the JUMPStart program and collaborations like the ESICM Fresenius Kabi Clinical Nutrition Award. In 2025, the award honored a study focused on critically ill patients with acute kidney injury who require continuous renal replacement therapy and are at high risk of nutritional deficiencies. The study aims to generate evidence to improve nutritional management and patient outcomes during and after continuous renal replacement therapy (CRRT). This innovative approach demonstrates Fresenius Kabi’s commitment to enhancing patient care and advancing medical education.
Sustainability in our value chain
Discover how sustainability plays a role at our production sites, particularly in the manufacturing of infusion solutions.
Driving positive change: Our dedication to sustainability
Interested in finding out more?
Disclaimer
Fresenius Kabi is a fully consolidated subsidiary of Fresenius SE. This website includes an overview of the Fresenius Kabi sustainability commitment. All data on this website corresponds to a subset of group data that is published in the Fresenius Group Sustainability Statement 2025 and thus is assured by an external auditor. The Sustainability Statement is prepared in full compliance with applicable legal requirements, incl. the European Sustainability Reporting Standards (ESRS).